Authors: Yamamoto, Yorihiro | Yamashita, Satoshi
Article Type:
Research Article
Abstract:
To assess the degree of oxidative stress, we measured plasma ubiquinone‐10 percentage (%CoQ‐10) in total amounts of ubiquinone‐10 in patients with chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma, and in age‐matched control subjects. %CoQ‐10 values were 12.9 \pm 10.3 (n={} 28), 10.6 \pm 6.8 (n={} 28), 18.9 \pm 11.1 (n={} 20), and 6.4 \pm 3.3 (n={} 16), respectively, showing a significant increase in oxidative stress in patient groups as compared to control subjects. There were no differences in total amounts of ubiquinone‐10 and ubiquinol‐10 among the four
…groups. We next measured %CoQ‐10 in plasmas obtained from nine patients treated with percutaneous transluminal coronary angioplasty (PTCA). Plasmas were collected when hospitalized, and at the time (0, 4, 8, 12, 16, and 20 hr, and 1, 2, 3, 4, and 7 days) after the PTCA. %CoQ‐10 values before and right after PTCA were 9.9 \pm 2.8 and 11.4 \pm 2.0, respectively, reached a maximum (20–45) at 1 or 2 days later, and decreased to 7.9 \pm 2.7 at 7 days after PTCA, indicating an increase in oxidative stress in patients during coronary reperfusion.
Show more
Keywords: Ubiquinol, ubiquinone, oxidative stress, hepatitis, cirrhosis, hepatoma, percutaneous transluminal coronary angioplasty (PTCA)
Citation: Biofactors,
vol. 9, no. 2-4, pp. 241-246, 1999
Price: EUR 27.50